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Technological forecastingAn essential step in the development of products based on biotechnology is an assessment of their potential
economic impacts and safety, including an evaluation of the potential impact of transgenic crops and practices
related to their cultivation on the environment and human or animal health. The purpose of this paper is to
provide an assessment method to evaluate the impact of biotechnologies that uses quantifiable parameters and
allows a comparative analysis between conventional technology and technologies using GMOs. This paper
introduces amethod to perform an impact analysis associatedwith the commercial release and use of genetically
modified plants, the Assessment System GMPMethod. The assessment is performed through indicators that are
arranged according to their dimension criterion likewise: environmental, economic, social, capability and
institutional approach. To perform an accurate evaluation of the GMP specific indicators related to genetic
modification are grouped in common fields: genetic insert features, GM plant features, gene flow, food/feed field,
introduction of the GMP, unexpected occurrences and specific indicators. The novelty is the possibility to include
specific parameters to the biotechnology under assessment. In this case by case analysis the factors ofmoderation
and the indexes are parameterized to perform an available assessment.
© 2009 Elsevier Inc. All rights reserved.1. Introduction
An essential step for the development of a genetically modified
plant (GMP) is the assessment of its safety. This procedure evaluates
all possible influences of the plant and practices related to its
cultivation on the environment and on human or animal health.
This is accomplished through adequate comparisons between the
target of genetic manipulations and organisms with similar traits, for
example, wild genotypes of the plant used to produce the GMP. This
evaluation is performed by impact analysis.
The GMP impact assessment, in general, may be a helpful tool for
decision-making process. Search engines and systemized data compres-
sion tools, which allow the generation of traceable conclusions, are key-
elements to assure that the decision-making process culminates in the
appropriate biotechnology management, with the best resources and
results. This study proposes a methodological system to evaluate the
impacts of biotechnologies, providing information organized according
to criteria and indicators of several areas where the impact can be
perceived in a direct or indirect manner: social, economic, environ-
mental, institutional and capacity development (General Assessment);
genetic insert features, GM plant features, gene flow, food/feed field,+55 19 33112640.
Jesus-Hitzschky).
l rights reserved.introductionof theGMP, unexpectedoccurrences and specific indicators
(Technical Assessment).
The proposed system is based on previous methods of risk analysis
and impact assessment, such as GMP-RAM METHOD — Risk Assess-
ment Method for Genetically Modified Plants (Jesus et al., 2006),
INOVA-tec System — Impact Assessment System for Technological
Innovation (Jesus-Hitzschky, 2007) and Environmental Impact
Assessment methods utilized during ISO 14000 implementation.
Many validated issues or parameters of analysis described in previous
reports (EFSA, 2006; OCDE, 2005; FAO, 2004; Conner et al., 2003; NAS,
2002) were also considered. The AS-GMPMethod allows the evaluator
to point out the specific parameters to evaluate his/her biotechnology
enabling the analysis of each particular case, so that the GMP can be
applied in a responsible and sensible way.
This information is organized into three tools: (1) worksheets to
compile Prospective Range, through the Significance Index; (2) indi-
cators worksheets to compile an Impact Level Performance defined by
the Magnitude Index. Finally the combination of both Indexes
(Significance×Magnitude) designs the (3) Matrix of Impact that is
built by theGeneral ImpactValue. TheAS-GMPMethodworks as a guide
pointing to indicators which should be analyzed and to the components
that may have some importance in the evaluation hence the method
contributes to reduce subjectivity.
In this way it allows, as a whole, the reduction of negative impacts,
and the best use of resources for GMP introduction so that the
prevention and mitigation of environmental damages can be achieved.
Fig. 1. Structure of AS-GMP Method.
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experiments, or even lab assays with GMP are evaluated by AS-GMP
method. Therefore, the method can be used throughout GMP develop-
ment, from the researcher during new trait search to the regulators
during assessment for market clearance. Obviously, the exchange of
information and experience among all involved parts allows an accurate
analysis of GMP safety. Themethod can be used by program and project
evaluators, managers and also regulatory and supervisory agencies. To
allow a better comprehension of this system, it is presented in a digital
format1 (AS-GMP Method v.1.0. Software) and its three tools are linked
so that the user can fill the information in the worksheets and
automatically observe the results in tables, graphics and matrices. It
also presents a conclusive report.
1.1. Transgenic crop environment and AS-GMP Method
Themain purpose of themethod is to improve the rapid evaluation
of possible impacts of the commercialization of transgenic crops,
compatible with the existing restraints put on costs and time by the
situation of the majority of Biotechnology Safety Committees, mostly
in developing countries.2 However, the method allows evaluating ex-
ante and ex-post the development of GMP on themarket, contributing
to the concept of sustainability (Fig. 1). The AS-GMPMethod has a low
cost, but allows a wide evaluation, showing the indicators at several
levels. It is also able to act directly within the scope of research
institutions and biotechnology companies, and to indirectly promote
the discussion of proposition of new biotechnology policies. A spin-off
of AS-GMP Method is the adequacy or generation of public and1 Soon available for download at the website of Embrapa Meio Ambiente: http://
www.cnpma.embrapa.br/forms/as_gmp.php3.
2 The Multicriteria Analysis can be seen as a more sophisticated alternative to rapid
appraisal approaches. According to Zackiewicz (2005), Multicriteria Analysis frame-
work has been developed as an aid for evaluating decisions, choices that could provide
a basis for ex-ante selection of projects related to biotechnology and the diffusion of
GMP. Though, it has an impact evaluation perspective, hence, an ex-post approach.
However, the two kinds of evaluation must be used in their own time for a better
possible achievement on the research effort allocation, improving public research
portfolio choices. This kind of approach uses a specifically developed methodology to
integrate economic with environmental, social, and building capability dimensions.
The progress of the assessment of these new frameworks have allowed to evaluate
problems raised on the treatment of economic impacts, when one moves away from
the Cost-benefit analysis and Cost-effectiveness to a more comprehensive framework.Research & Development policies more suitable to the innovative
process, in away that the comprehensive assessment of biotechnology
allows a rational environmental management allied with the
accountability of clearness in the results.
Fig. 1 is a schema of AS-GMP Method, showing its potentiality of
use by several actors, interests and assessment timing. In case the
assessment has a prospective interest the analysis must be done ex-
ante the technology use, focusing on the ‘Prospective Range’ and
illustrating its focus on potential impacts assessment.
It is possible to point out why probably therewould bemore interest
in this kindof analysis: funding agencies, investors anddecision-makers,
in order to decide among a project portfolio or what is the range of a
funded innovation. The assessment ex-post of the innovation develop-
ment foresees the assessment of all indicators, gathered in accordance
with the assessment criteria on its fields and which analysis allows the
clarification of ‘Impact Level Performance’. The analysis of the range or
prospective assessment and the choice of the Indicators of Performance
in order to prepare the structure of the impact matrix and therefore to
elaborate the ‘GMP Scenario’ is part of general impact assessment. The
general analysis of impacts and GMP scenario must be the focus of the
analysismadeby regulatoryand supervisory agencies, technology buyer
companies and society on the whole.
The cost of regulatory release and compliance is already the most
important roadblock for public goods research projects in this field (De
Greef, 2004). Alternative approaches to regulate new crop biotechnol-
ogies could be less expensive, but to date the private and social costs of
the current regulatory system have not been analyzed or measured, let
alone compared with alternatives (Kalaitzandonakes et al., 2007). The
AS-GMP Method/Software will be available cost-free at Embrapa Meio
Ambiente (Environment) website. It will impact favorably the biosafety
assessments for regulatory submissions since the method indicates the
most important parameters that have to be addressed in researches or
experiments, avoiding data duplicationwhich gathers needless require-
ments and wastes biosafety assessment money.
2. The description of the AS-GMP Method
2.1. Biotechnology characterization
In order to carry out biotechnology assessment first of all it is
recommended to perform the GMP characterization in order to assure
Table 1
Moderation factors for Significance IndexGen estimate.
Table 2
Data of the genetic insertion safety.
Data/tests previously
performed
Occurrence Development stage Results
obtainedInitial (1)
Yes No Advanced (2) Favorable (+1)
1 0 Conclusive (3) Unfavorable
(−1)Not studied (0)
i) Data/tests of genetic
insertion safety
ii) Tests of stability
of the insertion
iii) Tests of stability
of the new feature
iv) Evaluation of
agronomic applications
v) Tests of innocuity of
the new product (aimed
at pharmaceutical
or cosmetic)
vi) Tests of feed safety
(substantial equivalence)
Table 4
Reproductive characteristic of the recipient.
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its application performance.
The necessary information to collect the most relevant data in
order to assure acuity of assessment is presented below. This infor-
mation is presented on the first page of AS-GMP Software.
2.2. Information about GM plant
2.2.1. Description of the trait(s) and characteristics which have been
introduced or modified
A description of the trait and the changes it produces on the plant
phenotype is required (EFSA, 2006). Phenotypic modifications should
be quantified in relation to the comparable non-GM plant. The targets
of the trait should be identified as well as the sensitivity of non-
targets. The purposes of the genetic modification and the uses of the
GM crop should be described together with changes in the crop
composition, management, cultivation, deployment, geographic range
and end use.
2.2.2. Information on the sequences actually inserted or deleted
Applicants should provide information on (EFSA, 2006): (a) the size
andnumberof copies of all detectable inserts, both complete andpartial;Table 3
Localization of the plantation.
Localization of the site where the GMP will grow Yes No
Center of diversity of the recipient species −1 0
Center of origin of the recipient species −2 0(b) the organization of the inserted genetic material at the insertion site
andmethodsused for the characterization; (c) in caseof deletion(s), size
and function of the deleted region(s); and (d) sub-cellular location(s) of
insert(s) (nucleus, chloroplasts, mitochondria maintained in a non-
integrated form) and methods for its determination.
2.2.3. Genomic databases for the crop species
With regard to flanking sequences in general the GMO panel is
aware that comparative sequence analysis may not always be possible
due to limited genomic databases for the crop species in question.
2.2.4. Methods used for expression analysis
The methods used for the analysis of gene and protein expression
must be provided.
2.2.5. Donor features
2.2.6. Recipient feature: rate and distance of outcrossing
2.2.7. Information on how the GM plant differs from the recipient plant
in terms of: reproduction, dissemination, and survivability
2.2.8. Application scope: it is needed to define what is the target of the
genetic modification
(a) Solving agronomic problems: aiming to decrease agrotoxic
applications, pest resistance, weeds, environmental stress (salinity,
drought); (b) agricultural management practices: herbicide resis-
tance; (c) improvement of product quality: processing or nutritional
improvement; and (d) pharmacological intention.
2.3. Genetically modified plants assessment
The assessment is performed through the analysis of indicators
which are arranged according to their area criteria (coded with
letters) in two ways: general or technical such as: environmental
(A), institutional (B) capacity development (C), economic (D), social
(E) (General Assess); genetic features (F), GM plant features (G), gene
flow (H), food/feed field (I), introduction of the GMP (J), unexpected
occurrences (K) and specific indicators field (L) (Technical Assess).
The novelty is the possibility to add specific parameters to the GMP
under assessment. In this case by case analysis the factors of
moderation and the indexes are parameterized to run helpful
assessment. Three tools support the Proposed Impact Assessment
Method for Genetically Modified Plant ‘AS-GMPMethod’: (a) worksheets
to compile the Prospective Range, through the Significance Index;
(b) indicator worksheets to compile an Impact Level Performance
defined by the Magnitude Index. Finally the combination of bothTable 5
Risk perception of the GMP or its application.
Risk perception of the GMP or its application Weight
Risk perception null (no kind of sues perpetrated
against similar technology)
0
Unfavorable risk perception −2
Benefit perception tested by groups of interest
associated with technology use
+2
Table 6
Worksheet of indicators to compile an Impact Level Performance: the Magnitude IndexGen — Environmental field (A).




Water resources, soil and air
2 Water quality (turbidity, OBD, etc … due to innovation introduction) Gets worse (−1)/maintains (0)/gets better (1)
2 Heavy metal amount due to innovation introduction Increases (−1)/maintains (0)/decreases (1)
2 Chemical or organic residues (industrial sewer, waste, etc) Increases (−1)/maintains (0)/decreases (1)
2 Air pollutants emission in the air due to innovation introduction Increases (−1)/maintains (0)/decreases (1)
2 Change on natural resources demand (comparative analysis of use and
consumption of water, soil, mineral)
Increases (−1)/maintains (0)/decreases (1)
Biological resources: microorganism, flora and fauna
2 Change on ecosystem balance (change on ecological level:
microorganisms, flora and fauna)
Affects individual (−1)/affects community
(−2)/does not affect any ecological level (0)
2 Occurrence of negative effects on plants, animals and human health
(occurrence of diseases, contamination and/or death)
Yes (−1)/
No (0)
2 Change on natural resources demand (comparative analysis of animal
and/or vegetal use and consumption)
Increases (−1)/maintains (0)/decreases (1)
Environmental conservation
2 aEnvironmental management or monitoring practice Creation (2)
Comparative analysis with conventional methods. The management used
prior to the innovation was effective for environmental conservation matters.
Improvement (1)
Does not interfere (0)
Extinction (−2)
Environmental recovery
3 aReduction of level of solid, chemical and biological pollutants Yes (1)/no (0)
3 aBiodegradation Mechanisms Creation (2)/
The innovation is a biodegradation mechanism that recovers a degraded area. Improvement (1)/
Does not apply (0)
3 aGives stability to a threatened ecosystem Yes (1)/
Comparison with the ecosystem prior to innovation introduction No (0)
a Potential impact (ex-ante): indicators used for ex-ante technology assessment.
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Impact that is created by the General Impact Value.
2.3.1. Worksheets to compile Prospective Range: the Significance IndexGen—
General Assessment
The first tool identifies a prospective analysis of the objective related
to the use of a specific biotechnology. In this phase of assessment the
following moderation factors are considered: spatial range, reach and
influence. This first part of the assessment may be used in ex-postTable 7
Worksheet of indicators to compile an Impact Level Performance: the Magnitude IndexGen




2 aAgreement made (through a formal contract).
A formal contract for the realization of the research or
development project with at least one partner.
Financial assistance
2 aFinancial assistance ways
(high-risk fund, angel investor…).
Partnerships
2 aNumber of partners. Total number of partners
(public, private, political instances, NGOs, civil organizations.
Quality system implemented
2 aISO or another quality certificate.
If a partner has one or more quality certificates
(ISO 9001; 14000; or another one).
2 Normative service. Ex-antea: Yes.
a Potential impact (ex-ante): indicators used for ex-ante technology assessment.assessment aswell as in ex-ante assessment, either by an evaluatorwho
is going to decide about a GMP application or by funding agencies/
investors which are going to choose among biotechnology projects
when deciding the destination of financial resources.
Thesemoderation factors are showed in aworksheet that gives values
to the importance and significanceof the factor in termsof the Extentof its
use – local, regional, national and international – and the direct or indirect
Scope of their application (environment, human health, product or
process quality, social, economic, political and legal). The analysis of these— Institutional development field (B).
n Factor's weight range Correction factor
Formal contract (2)/protocol
without legal value or a letter of
intent (1)/does not have (0)
Has financial assistance (1)/does
not have (0)
Note of the number of
partnerships (+1)
Partner focus: social projects (+1)/
Environmental environmental projects (+1)
Give (+1) one point for each
quality system implemented
(in each partner institution)
Yes (1)/no (0)
Table 8
Worksheet of indicators to compile an Impact Level Performance: the Magnitude IndexGen — Capacity field (C).
Weight Indicator/moderation factor Data/information
for evaluation
Factor's weight range Correction factor
Capacity field
Formation of human resources
2 aNumber of trainees (scholarship holders
involved in research or development of
the innovation; formal).
Give (+1) one point for each
trainee (in each partner institution).
2 aNumber of graduate students Masters,
PhD, Post-Doc, MBA, involved in the
research or development of the
innovation.
Give (+1) one point for each
graduate student involved
(in each partner institution).
Trainings
2 aTechnical trainings (trainings directly related to
R&D activities to capacitate the involved team)
Give (+1) one point to each
training carried out for the
development of the innovation.
Number of participants: Up to 10%
of the employees of the organization
(+1)/over 10% (+2)
2 aLectures or trainings related to quality systems
(project team members and collaborators)
Give (+1) one point to each
training carried out for the
development of the innovation.
Number of participants: Up to 10% of
the employees of the organization
(+1) / over 10% (+2)
Scientific production
2 Defended MSc dissertations
associated to the innovation.
Give one point for each finished
dissertation related to the
innovation (+1)
2 Defended PhD theses associated
to the innovation.
Give one point for each finished thesis
related to the innovation (+1).
2 Scientific papers published in national
or international journals of the
innovation sector.
Give one point for each published
paper related to the innovation (+1)





2 Number of abstracts in proceedings and
presentations in conferences.
Give (+1) one point for
each presented work related
to the innovation.








a Potential impact (ex-ante): indicators used for ex-ante technology assessment.
Table 9
Worksheet of indicators to compile an Impact Level Performance: the Magnitude IndexGen — Economic Field (D).
Weight Indicator/moderation factor Data/information
for evaluation
Factor's weight range Correction factor
Economic Field
3 Financial return (cost reduction — work force reduction,
economy of raw material, energy etc.)
Occurs (1) Factor
Does not occur (0) Up to three years (+2)/3 to
5 years (+1)/over 5 years(0)
2 aQualitative return (process improvement,
normative service, knowledge multiplication etc.)
Occurs (1)
Does not occur (0)
3 aForeign currency increased
(perspective of international trade relationships)
Occurs (1)
Does not occur (0)




2 aControl of productive chain (if innovation components come





2 aMarket where the innovation will be inserted. Monopoly (−2)
Oligopoly (−1)
Competitive (0)
2 aMarket perspective (demand size) High (2)/medium (1)/low (0)
2 aProduct life cycle (time during which the product
will stay on the market)
Long (1)
Short(0)
2 aEntry barriers (difficulties to enter the market) High (−1)
Low (1)
3 aValue added. High (1)
High technology, high knowledge level and R&D investment results Low (0)
3 aThe innovation may be commercialized Yes (+1)
If the final object of the innovation has potential to be commercialized. No (0)
a Potential impact (ex-ante): indicators used for ex-ante technology assessment.
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Table 10
Worksheet of indicators to compile an Impact Level Performance: the Magnitude IndexGen — Social Field (E).
Weight Indicator/moderation factor Data/information
for evaluation
Factor's weight range Correction factor
Social field
Work relations
3 Influence on work conditions
(worker health and safety)
Improves (1) keeps (0)
worsens (−2)
3 Reduction of jobs Demission (−1)
Fair reallocation (0)
3 Creation of jobs. (direct/indirect) Occurs (2) Factor 1 Factor 2
Does not occur (0) Temporary (+1) Direct (+2)
Permanent (+2) Indirect (+1)
Social reach
2 aSocial class that benefits from the
innovation
Occurs (1) Class A (+1)/class B (+2)/class C (+3)
Does not occur (−1) Class D (+4)/class E (+5)
Science popularization
2 Number of lectures and courses
given, number of participants and
kind of audience.
Give one point (+1) to each
presented lecture related to
the innovation.
Factor 1 Factor 2
National (+1) Number of participants. — up
to 50 (+1)/over 50 (+2)Intern. (+2)
2 Articles in newspapers/media Give one point to each article
related to the innovation.
Factor
National (+1)/Intern. (+2)
a Potential impact (ex-ante): indicators used for ex-ante technology assessment.
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(Table 1). It is given a range of values to each moderation factor of
innovation. Each weight given to the moderation factors will be
considered for the generation of the Significance IndexGen, according to
the formula below:
Σ Scopea;g × Influencea;g
 
= BiotechnologyRange
BiotechnologyRange × Extent = Significance IndexGen:
2.3.2. Worksheets to compile the Scenario for the GMP Introduction: the
Significance Indextech — Technical Assessment
The scenario of the GMP is composed of safety information that has
been already searched in a laboratory essay or based in the literature
(Table 2): i) data/tests of the genetic insertion safety; ii) tests of stability of
the insertion, iii) tests of stability of the new feature, and iv) evaluation ofTable 11
Worksheet of indicators to compile an Impact Level Performance: the Magnitude IndexTech
Weight Indicator/moderation factor
Genetic Insert Features Field
Genetic insert
2 Dissemination of diseases, development of antibiotic resistance.
2 Presence of unwanted, regulatory or marker nucleotide sequences that prese
2 Known ORFs — open reading frames (if potential chimeric ORFs are identified b
should be conducted to investigate the possibility for similarities with known to
Appearance of other negative characteristics
2 Stability of the insert
2 Phenotypic and compositional differences, pest and disease reactions
Expressed protein
2 Occurrence of negative effects on plant, human or animal health
2 Protein specificity
2 Homology with known allergenic or toxic proteins
2 Protein stability
2 Transcriptional and/or translational data (may be required to investigate
if novel proteins are synthesized)
2 Mitochondria or chloroplasts flanks the insert (as can occur with biolistic
delivery methods)
Effects on non-target organisms
3 Occurrence of negative effects on non-target organisms
3 Protein toxicity or allergenicity for non-target organismsagronomic applications, tests of innocuity of the new product (aimed at a
pharmaceutical or cosmetic), or tests of feed safety (substantial
equivalence). In the item iv) just one characteristic must be filled. Each
weight given to moderation factors will be considered for the generation
of the Significance Indextech, according to the formula below (Tables 3–5):
Σ Occurrencei;iv × Developmental stagei;iv × Result obtainedi;iv
 
= Safety tests Table 2ð Þ
Safety test + Plantation site + Reproduction sp + Riskperception
= Significance Indextech:
2.3.3. Indicators worksheets to compile an Impact Level Performance: the
Magnitude Index
The second tool consists on preformatted worksheets (Tables 6–17)



















Occurs (−1)/does not occur (0)
Occurs (−1)/does not occur (0)
Table 12
Worksheet of indicators to compile an Impact Level Performance: the Magnitude IndexTech — Features of GM Plant Field (G).
Weight Indicator/moderation factor Data/information
for evaluation
Factor's weight range
Features of GM Plant Field
Generation of plants with weedy aspects
2 Alteration of reproductive, competitive or adaptive ability. Yes (−1)/no (0)
2 Recipient plant with weedy aspects. Yes (−1)/no (0)
Outbreak of additional attributes
2 Gene specificity. Yes (1)/no (0)
2 Biological features that affect fitness and environmental sensitivity
(e.g. multiplication, dormancy, survivability, dispersal).
Yes (−1)/no (0)
Information on the expression of the insert
2 Information on developmental expression of the insert during the life cycle of the plant Improves (1)/maintains (0)/worsens (−1)
2 Changing in biology and agronomic traits, including common breeding parameters
(e.g. plant morphology, flowering time, duration of pollen viability).
Yes (−1)/no (0)
2 Expression of potential fusion proteins (should be investigated by bioinformatic analysis) Yes (−1)/no (0)
2 Changes in susceptibility to important pests and diseases. Increase (−1)/decrease (1)/does not alter (0)
Mechanism of interaction between the GM plant and target organisms
2 Expression and mode of action is specific to target organism of any new traits present
in the modified plant.
Specific (1)/non-specific (−1)/there is
no target organism in the event (0)
Interactions between the GM plant and its biotic environment
2 Effects on the numbers and diversity of relevant populations of species in the receiving
environment (plant, animal, microbe);
Affects individual (−1)/affects community
(−2)/does not affect other organism (0)
2 Altered susceptibility to pests and pathogens facilitating the dissemination of infectious
diseases and/or creating new reservoirs or vectors
Increases susceptibility (−1)
Decreases susceptibility (1)
Does not alter susceptibility (0)
2 Compromising prophylactic or therapeutic medical, veterinary, or plant protection treatments Improves treatment (1)/worsens (−1)/does
not affect (0)
2 Effects on beneficial plant–microbial associations and biogeochemistry
(biogeochemical cycles), particularly on microbial-mediated carbon and nitrogen
recycling through changes in soil decomposition of organic material.
Yes (1)/no (0)
Potential interactions with the abiotic environment
2 Alteration of climatic conditions (e.g. altered production of greenhouse gases). Improves (1)/maintains (0)/worsens (−1)
2 Altered sensitivity to, or tolerance of climatic conditions (e.g. cold, heat, humidity). Improves (1)/maintains (0)/worsens (−1)
2 Altered sensitivity to, or tolerance of abiotic fractions of soil (e.g. salinity, mineral
nutrients, mineral toxins).
Improves (1)/maintains (0)/worsens (−1)
2 Altered sensitivity to, or tolerance of gases (e.g. CO2, oxygen, NH3). Improves (1)/maintains (0)/worsens (−1)
2 Alteration of mineralization (e.g. root exudates changing the soil pH). Improves (1)/maintains (0)/worsens (−1)
Persistence and invasiveness
2 GM plant becomes more persistent or invasive than the non-GM counterpart. Yes (−1)/no (0)
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magnitude of the parameters.
The goal of this method creation is to consider the indicators
assessment within every possible field, without privileging any para-Table 13




3 Unexpected dissemination due to outcrossing with
conventional genotype
Alteration in the population distribution of weed or native species
3 Outcrossing with weed or wild species.
Alteration in other non-target organisms
3 Gene flow to non-target organisms (horizontal flow)meter. In this way, AS-GMPMethod foresees the regulation of weights,
but does not prioritize fields.
In case of an ex-post assessment, the indicators worksheet must









Worksheet of indicators to compile an Impact Level Performance: the Magnitude IndexTech — Food/feed Field (I).





2 Processing and/or preserving needs
(compared with its non-GM counterpart)
Increases needs (−1)/decreases needs (1)/does not alter (0)
2 Threat to agricultural management practices.
Comparative analysis with conventional methods
Increases needs (−1)/decreases needs (1)/does not alter (0)
Nutritional assessment
2 The dietary role of the product and the expected level of use. Yes (1)/no (0)
3 Nutrient composition — alteration after the genetic insertion. Improves (1)/maintains (0)/worsens (−1)
3 Biological efficacy of nutrient components in the food Improves (1)/maintains (0)/worsens (−1)
2 Assessment of dietary intake and nutritional impact. Improves (1)/maintains (0)/worsens (−1)
Commercial management regimes
2 Changes on applications of plant protection products
(pesticides and/or biocontrol agents), for the GM plant where
these are different from the equivalent non-GM plant.
Increases needs (−1)/decreases needs (1)/does not alter (0)
2 Changes on rotations and other plant management measures
for the GM plant where these are different from the equivalent non-GM plant.
Improves (1)/maintains (0)/worsens (−1)
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star) must be analyzed.
Eachweight given to indicators or moderation factors will be taken
into account when generating the Magnitude Index, according to the
formula below:
IndicatorWeighta;l × Weight rangevaluea;l + Σ Correction Factorsa;l
 
= TotalWeight of Indicators fromFieldA = Totalweight of FieldA
Σ TotalWeight of FieldA;B;C;D;Eð Þ=Number of FieldsAnalyzed
= Magnitude Index General Impact Indexð Þ
Σ TotalWeight of Field F;G;H; I; J;K; Lð Þ = Numberof FieldsAnalyzed
= Magnitude IndexTech Technological Impact Indexð Þ:
2.4. Fields for indicator description, indicator weight, factors of moderation
and criteria of assessment
On the worksheet the parameter or indicator under assessment is
grouped within its field according to its criterion or characteristic.
These items are predetermined on the worksheet in order to allow an
accurate evaluation of related impacts.
These summarized data on the indicators worksheet were identified
and compiled with the contribution of experts from several areas of theTable 15
Worksheet of indicators to compile an Impact Level Performance: the Magnitude IndexTech
Weight Indicator/moderation factor Data/inform
Introduction of the GMP Field
Technological advancement
2 Threat to the agricultural management practices
2 Comparative analysis with conventional methods
Decreases in the efficacy of the technology
3 Probability to generate mutations in the target organisms
Increasing the demand for natural resources
2 Comparative analysis regarding soil and water usage and qualityassessment approach. This counsel was carried out through personal
interviews, with the purposes of: firstly to identify and consolidate the
necessary indicators and thereafter to make adjustments on indicators'
weights and weight ranges of each moderation and correction factors,
when necessary. Some tests were accomplished for adjustments not
only on used parameters but also on the functionality of the support
Software for the system application.
To each indicator presented on Tables 6–17 the method gives a
weight, which varies from 1 to 3. This variation in weight is done as
follows: indicators that show a higher weight are the ones with
potentialized impact. For example, in the case of Environmental Field
the indicators of environment recovery have weight 3, since according
to this item a certain environment may be recovered potentializing its
future use for conservation or preservation. On the same way, it is
given the maximum value (3) to the field ‘unexpected events’ since it
brings the possibility of adverse or undesirable effects. On the other
hand, indicators added by users have weight 1, so that the final result
does not suffer great distortions.
In spite of creating a hierarchy within each field, this will not be
used for the decision-making but for a scenario generation and so the
general panorama of the GMP environment. In this way, the fields'
weights are the same, since they are considered equally important. In
other words, the biotechnology assessment should contemplate the
use of AS-GMP Method in each of its fields. In case an indicator is not
significant for the GMP under analysis it should be ignored, in the
same way more specific new indicators for the evaluation can be
added to the field “Specific indicators”.— GMP introduction field (J).
ation for evaluation Factor's weight range
Improves (1)/maintains (0)/worsens (−1)
Improves (1)/maintains (0)/worsens (−1)
Increases (−1)/decreases (1)/does not alter (0)
Increases needs (−1)/decreases needs (1)/does not alter (0)
Table 16
Worksheet of indicators to compile an Impact Level Performance: the Magnitude IndexTech — Unexpected occurrences field (K).




2 Adverse environmental effect Occurs (−1)/does not occur (0)
2 Possibility of improper use of the GMP Occurs (−1)/does not occur (0)
2 Damage to human, animal or plant health Occurs (−1)/does not occur (0)
2 Lawsuit against the GMP Occurs (−1)/does not occur (0)
2 Risk of adopting the technology related to the characteristic of the GMP. High (−2) Medium medium (−1) low (0)
2 Information on any toxic, allergenic or other harmful effects on human
or animal health arising from the GM food/feed
Occurs (−1)/does not occur (0)
GMO dissemination due to extreme climatic events
3 Geographic connection to sensitive areas in the region Yes (−1)/no (0)
3 Site location — proximity of problematic areas (e.g., field trial located
in the property near a river).
Yes (−1)/no (0)
3 Period of occurrence of extreme climatic event Coincidence (−1)/not coincidence (0)
GMO dissemination due to operational failure
2 Training of the team Necessary (−1)/desirable (1)/no need (0)
2 Final destination of the GMO Expensive (−1)/cheap (1)/the same as non non-GM plant (0)
Dissemination due to theft of material
3 Physical safety of the property Yes (1)/no (−1)
Toxicology
3 Toxicology tests in mammals. Positive result (−1)/negative result (1)
2 Identified new constituents other than proteins which should be evaluated. Occurs (−1)/does not occur (0)
Allergenicity
3 Newly expressed protein has allergenic characteristics (e.g. Pepsin resistance test,
glycosylation site, IgE reaction).
Yes (−1)/no (1)
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some fields or to perform just one kind of analysis either General or
Technical because the results are presented separately. Otherwise it is
suggested that thewhole analysis bound is executed in order to have a
complete assessment.
2.5. Data/information for the evaluation field
This central column is the field where the user describes all
information related to the criterion of assessment. Literature searches
or prospective data must be the source of scientific data, described to
perform the ex-ante analysis or the scenario elucidation of the GMP.
Experimental results from GMP application must be used as the
assessment basis, that is, for weight allocation. These collected data
must be inserted in the worksheet's central column in order to ensure
the acuity and support of the achieved results.
These data will be shown on methodology results in electronic
format (AS-GMP v1.0 Software) as a ‘descriptive report’.
2.6. Matrix of impact that is built by the General/Technical Impact Value
The third tool provides a structure to observe the potential impact
and the prospective scenario to introduce the GMP, in the ex-ante
analysis. In the ex-post evaluation, that uses the Significance IndexTable 17
Worksheet of indicators to compile an Impact Level Performance: the Magnitude














(−1 to +1)and all indicators to build the Magnitude Index. These both indexes
are crossed to show the final result form: the analysis in a matrix
format (Figs. 2 and 3).
After the identification of the technology scope, GMP characteriza-
tion, impact assessment, and the significance analysis of related
effects, the final step in this impact assessment process comes in —
reviewing the potential impact and establishing at which level impact
management, through preventive or corrective actions, must be taken
in order to allowan effective and safe use of the transgenic crop. This is
performed by the Matrix of Assessment.
TheMatrix (Figs. 2 and 3) is constructedwith two axes, where the x-
axis stands for the classes of the Index of Magnitude (indicators
performance) and the y-axis stands for the classes of the Significance
Index (Prospective Analysis/Scenario for the GMP Introduction). That is
indicated in the matrix ‘General/Technical Impact Value’, which is the
final result of all indicators of all fields. To complement the evaluation
the results from the Magnitude and Significance Indexes for each field
are plotted in the Matrix according to their position (points are plotted
using letters that represent each field). The general value for the field
performance is the result of the sums of all indicator values inside the
field under evaluation. The illustration of this result of the field
evaluation (plotting the letters like a code) allows formulating a list of
recommendations with the objective of potentializing a positive impact
of the GMP on eachfield. Thismeasure favors the first proposition of the
system: fields should be considered equally important, and thus
corrective measures should be taken in order to mitigate distortions of
impacts between them.
The level of performance of the technology under evaluation is
classified as follows:
(1) Prospective assessment: unfavorable scenario to the GMP/GMP
in early implementation stage (potential impact assessment) or
with low perspective of success — GMP is not recommended.
(2) Prospective assessment: unfavorable scenario to the GMP/GMP
with low performance — restrictions and corrective actions are
recommended to the GMP.
Fig. 2. TheMatrix of General Assessment is the first step of this Impact Assessment tool. The Matrix of Assessment gives an overview of the general impact evaluation and establishes
at which level impact management must be taken. The information that is considered in this Matrix (General) is the Significance Indexgen (Prospective Range) and Magnitude
Indexgen (General Impact Index). The x-axis represents the classes of the Magnitude Index and the y-axis represents the classes of the Significance Index.
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with medium performance — monitoring with restrictions is
recommended to the GMP.
(4) Prospective assessment: unfavorable scenario to the GMP/GMP
with excellent performance — GMP is recommended.
(5) Prospective assessment: favorable scenario to the GMP/GMP in
early implementation stage (potential impact assessment) or with
lowperspective of success—managementwith restrictions is required.
(6) Prospective assessment: favorable scenario to theGMP/GMPwith
low performance— corrective actions are recommended to the GMP.
(7) Prospective assessment: favorable scenario to the GMP/GMP
with medium performance — monitoring or management is
required to the GMP.
(8) Prospective assessment: favorable scenario to the GMP/GMP
with excellent performance — GMP recommended.
(9) Prospective assessment: favorable scenario to the GMP — in-
vestments in the GMP are recommended/GMP low performance —
management required.Fig. 3. TheMatrix of the Technical Assessment is the final step of this Impact Assessment tool. Th
at which level impact management must be taken. The information that is considered in this
Magnitude Indextech (Technical Impact Index). The x-axis represents the classes of the Magnitu(10) Prospective assessment: scenario favorable scenario to the GMP—
investments are recommended/GMP lowperformance—management
required.
(11) Prospective assessment: favorable scenario to the GMP —
investments are recommended/GMP medium performance —
monitoring required.
(12) Prospective assessment: favorable scenario to the GMP — in-
vestments are recommended–GMP excellent performance — GMP
highly recommended.
2.7. Digital format — introduction of the software AS-GMP (V. 1.0)
The software AS-GMP v. 1.0 is an electronic format of the
worksheets, created in Microsoft Visual Basic v. 6.0, which can be
accessed at Embrapa Environment link: http://www.cnpma.embrapa.
br/forms/as_gmp.php3 (GMP impact assessment file to download). To
run the AS-GMP, just download the file to your PC and run it with a
double click.eMatrixof Assessment gives an overview of the general impact evaluation and establishes
Matrix (Technical) is the Significance Indextech (Scenario for the GMP Introduction) and
de Index and the y-axis represents the classes of the Significance Index.
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By using this electronic format, it is possible to attribute values to
the factors of moderation on the worksheets and to the results of the
indexes (Significance and Magnitude). Those will be calculated and
plotted in the Matrix of Impact automatically. These results can be
presented in table or graph format and also in the description report.
3.1. Compiled analysis
The following step involves compiling and analyzing the results from
the matrix and worksheets. Each field coded with a letter is plotted in
the matrix aiming to require some measures according to the level of
impact. These impact measures must consider all data described in the
worksheet, such as the specificity of theGMP, the activity under analysis,
release concerns and the scenario situation. Essentially, this compilation
is the core structure for performing impact management.
Aiming to potentialize the positive impact of the GMP on different
fields, the code that represents each field is plotted in thematrix's row
compatible with its performance. The visual and graphic data
presentation format facilitates to suggest corrective measures for its
optimization or mitigation of negative impacts. Therefore, for a proper
evaluation the user needs to formulate his/her list of recommenda-
tions specific to the GMP under analysis.
4. Conclusions
Prospective analysis must be carried out to predict the occurrence
of negative impacts of some GM crops on the environment or on
human health. Additionally, this analysis must forecast and optimize
economic, capability, institutional or social success. These assess-
ments allow us to define preventive measures to mitigate or avoid
negative effects related to genetic insert features, GM plant features,
gene flow, food/feed field, introduction of GMP, unexpected occur-
rences and specific indicators that could result in negative impacts.
This rapid appraisal allows us to define preventive measures to
mitigate or avoid adverse effects or unexpected occurrences that could
result from potential or identified hazards. Thus, it is possible to
develop a transgenic cropwith a high probability of success and safety.
The impact assessment proposed here includes parameters that
allow an estimate of the performance level, which is based on the
assignment of numeric values to several factors correlated with
impact. It results in lower subjectivity and higher clearness in the
analysis processes. Technologies with the same objectives can also be
compared using the proposed system.
Considering the range of different genetical modifications to be
evaluated and the performance behaviors and safety concerns that
must be addressed on a case by case basis, the proposed system may
not cover all aspects involved, though it presents a broad approach to
impact assessment. Since there is always a likelihood of development
of a new and better method that could be used in many situations, the
user is encouraged to expand the possibilities of this tool by adding or
deleting parameters according to the kind of technology addressed.
On the other hand, investors and regulators must evaluate whetherthe chosen parameters are the best to define the potential impact of
the GMP under analysis.
This strategy is very important to allow a less superficial method,
since it is able to identify which parameters are more correlated with
the transgenic crop. In addition, characterizing impact bymeasuring it
with quantifiable tools demonstrates a quantitative method where
subjectivity is drastically reduced. Compared to current processes, the
proposed method represents a less subjective and clearer process for
impact assessment.
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